Home › NCT06638021
Targeted EHR-based Communication of Diagnostic Uncertainty in the ED
Targeted EHR-based Communication of Diagnostic Uncertainty (TECU) in the ED: An Effectiveness Implementation Trial
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Patient Inclusion Criteria: * age 18 years or older * English language speaking * assigned a symptom-based diagnosis in the EHR clinical impression * planned for discharge from the ED during the enrollment visit * able to complete follow up assessments in 2 and 30 days * TECU best practice advisory (BPA) electronic health record alert activates during their discharge process Patient Exclusion Criteria: * under the age of 18 years * non-English speaking * clinically unstable, psychologically impaired or intoxicated, or otherwise unable to provide informed consent as judged by research staff member * admitted to hospital * unable to complete follow up in 2 and 30 days * previously enrolled in this study (during a prior ED visit)
About the study
The goal of the clinical trial is to evaluate the preliminary effectiveness and the implementation feasibility of the Targeted EHR-based Communication about Uncertainty (TECU) strategy in improving the quality of care transitions from the emergency department (ED) to home. The overall specific aims related to the trial are to test the preliminary effectiveness of TECU compared to standard of care in reducing patient uncertainty and return ED visits and evaluate the adoption of TECU, exploring patient and clinician barriers and facilitators to TECU implementation.
What is being tested
- Targeted EHR-based Communication of Diagnostic Uncertainty (TECU) (behavioral)
Sponsor: Thomas Jefferson University · Participants: 300 · Started: Nov 5, 2024
Contact the study team
- Kristin L Rising, MD, MS · Phone: 2673031359
- Amanda MB Doty, MS · Phone: 2155034619
Official record on ClinicalTrials.gov — NCT06638021
Locations in the U.S.
| Pennsylvania | Thomas Jefferson University, Philadelphia |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.